Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials
- Citation:
- Support Care Cancer vol 25 (11) 3537-44
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- 7
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Health Outcomes
- Pharmas:
- Grants:
- R01 NR015259, U10 CA180790, UG1 CA189823, R01NR015259
- Corr. Author:
- Authors:
- Jennifer Le-Rademacher Rahul Kanwar Drew Seisler Deirdre R. Pachman Rui Qin Alexej Abyzov Kathryn J. Ruddy Michaela S. Banck Ellen M. Lavoie Smith Susan G. Dorsey Neil K. Aaronson Jeff Sloan Charles L. Loprinzi Andreas S. Beutler
- Networks:
- LAPS-MN026
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-N08CA, NCCTG-N08CB
- Phases:
- 3
- Keywords:
- peripheral neuropathy, CTCAE, EORTC QLQ-CIPN20, patient-reported outcome, physician-reported outcome